As of 2026-09-20, the Relative Valuation of Gritstone Oncology Inc (GRTS) is (79.76) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.03 USD, the upside of Gritstone Oncology Inc based on Relative Valuation is -247795.2%.
The range of the Relative Valuation is (77.00) - (78.84) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 29.3x - 38.2x | 33.8x |
| Forward P/E multiples | 23.9x - 30.0x | 27.0x |
| Fair Price | (77.00) - (78.84) | (79.76) |
| Upside | -239225.8% - -244938.7% | -247795.2% |
| Date | P/E |